A nurse is assessing a 45-year-old patient who has been receiving furosemide therapy for heart failure. Which assessment finding would be the priority concern indicating a serious electrolyte imbalance?

Furosemide is a potent loop diuretic that works by inhibiting the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle. While this mechanism is highly effective for decongestion in heart failure, a major adverse effect is the excessive loss of electrolytes, particularly potassium and magnesium. The priority assessment for a nurse is to identify clinical manifestations that signal a life-threatening electrolyte disturbance. In the context of NCLEX-RN prioritization, a physiological problem that can rapidly lead to cardiac arrest takes precedence over less immediately fatal issues.

Cardiac dysrhythmias with a prolonged QT interval represent the most critical finding. Hypokalemia and hypomagnesemia, both common consequences of loop diuretic therapy, profoundly affect cardiac electrophysiology. A prolonged QTc interval signifies delayed ventricular repolarization, which creates a substrate for polymorphic ventricular tachycardia, including Torsades de Pointes. This is a direct precursor to cardiac arrest. Recent research on combination diuretic therapy in heart failure underscores the significant risk of electrolyte disturbances, with hypokalemia being one of the most frequently observed adverse events requiring careful monitoring ^[1]. Furthermore, a study examining the cardiac electrophysiological effects of diuretics in heart failure patients confirmed that monitoring the QTc interval and serum potassium levels is crucial, as these parameters are directly linked to the risk of malignant arrhythmias ^[3]. This finding directly threatens the patient's airway, breathing, and circulation (the "C" in the ABC prioritization framework), making it the undisputed priority.

• 
  Option 1: Muscle cramps, fatigue, and generalized weakness are classic and common symptoms of hypokalemia. While they are important assessment findings that indicate a developing electrolyte imbalance, they do not represent an immediate threat to life. The nurse would certainly note these and report them, but they are secondary to a finding that indicates active cardiac instability.
  


• 
  Option 2: Mild peripheral edema and slight weight gain suggest fluid retention, which is the very problem furosemide is intended to treat. This finding indicates that the current diuretic regimen may be ineffective, a common challenge in managing refractory fluid overload in heart failure ^[1]. The GUIDE-HF protocol highlights that residual fluid retention is a significant problem linked to poor outcomes, but its management is a longer-term treatment adjustment, not a moment-to-moment emergency like a lethal dysrhythmia .
  


• 
  Option 4: Decreased urine output and concentrated urine could point to dehydration or pre-renal acute kidney injury from over-diuresis. While this requires prompt intervention, such as temporarily holding the diuretic and assessing fluid status, it does not carry the same immediate, seconds-to-minutes risk of death as a prolonged QT interval leading to cardiac arrest. The evolving strategies for decongestion emphasize the importance of precise fluid management to avoid such complications, but the hemodynamic instability from a dysrhythmia is the more acute threat .
  

This question tests your ability to apply the nursing process (specifically, analysis and prioritization) using Maslow's hierarchy and the ABCs. A patient on furosemide is at high risk for hypokalemia. When you see a cardiac monitor showing a prolonged QT interval or the patient develops a new dysrhythmia, you must immediately connect this to a potential electrolyte crisis. The foundational knowledge here is that potassium and magnesium are critical for myocardial repolarization, and their depletion manifests on the ECG as QT prolongation, which is a setup for a fatal rhythm. The meta-analysis on combination therapy reinforces that this is not just a theoretical risk but a clinically observed adverse event that demands vigilant nursing surveillance ^[1]. The correct action is not simply to report the lab value, but to recognize the dysrhythmia itself as the most urgent clinical sign of that lab abnormality.